Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.

Oncotarget · 2017 · PMC5630397 · PMID 29029497

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

only marginally significantP=0.09so close (0.05 < p ≤ 0.1)

Tumor size >3cm was only marginally significant (P=0.09) (HR: 1.7; 95% CI: 0.91-3.4).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.